Citadel Advisors’s Tema Oncology ETF CANC Stock Holding History
Bought
Maintained
Sold
Other funds holding CANC
Citadel Advisors's CANC Position: Q3 2026 in Review
Citadel Advisors opened a new position in Tema Oncology ETF (CANC) in Q3 2026: 19,345 shares worth $813K. The stake represents ﹤0.01% of the portfolio and ranks #9015 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in CANC as recently as Q1 2026.
Citadel Advisors first reported a position in CANC in Q1 2026 and has held it in 2 quarters since. The position peaked at $2.54M in Q1 2026. 17 funds tracked by Wall St. Rank hold CANC as of Q3 2026.
- Citadel Advisors held 19,345 shares of Tema Oncology ETF worth $813K as of Q3 2026.
- Tema Oncology ETF was a new Citadel Advisors position in Q3 2026.
- Tema Oncology ETF made up ﹤0.01% of Citadel Advisors's portfolio in Q3 2026, its #9015 holding.
- Citadel Advisors first reported a position in Tema Oncology ETF in Q1 2026 and has held it in 2 quarters since.
- Citadel Advisors's Tema Oncology ETF position peaked at $2.54M in Q1 2026.
- 17 funds tracked by Wall St. Rank held Tema Oncology ETF as of Q3 2026.
Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.